Leucadia National Corporation »

Edgewise Therapeutics shares owned by Leucadia National Corporation

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by Leucadia National Corporation from 13F filings

Historical chart of Leucadia National Corporation investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by Leucadia National Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by Leucadia National Corporation

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.9M 71k 40.63

More positions owned by Leucadia National Corporation

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Spdr Series Trust St Str Sp Biot (XBI)
Apple (AAPL)
Spdr Gold Tr Gold Shs (GLD)
Advanced Micro Devices (AMD)
Meta Platforms Cl A (META)
Amazon (AMZN)
Iren Ordinary Shares (IREN)
NVIDIA Corporation (NVDA)
Ark Etf Tr Genomic Rev Etf (ARKG)
Automatic Data Processing (ADP)
Cloudflare Cl A Com (NET)

View all positions for Leucadia National Corporation

Top funds holding Edgewise Therapeutics

OrbiMed Advisors
Paradigm Biocapital Advisors
RA Capital Management
BlackRock
Jupiter Topco
Henderson Group
FMR
Novo A/S
Driehaus Capital Management
Perceptive Advisors
Vanguard Capital Management
Baker Bros. Advisors
Siren
Cormorant Asset Management
Morgan Stanley

View all funds holding Edgewise Therapeutics